https://news.medxy.ai/zh/%e9%95%bf%e6%9c%9f%e7%94%b2%e7%8a%b6%e8%85%ba%e7%99%8c%e9%9a%8f%e8%ae%bf%e8%83%bd%e5%90%a6%e5%ae%89%e5%85%a8%e8%bd%ac%e8%87%b3%e5%88%9d%e7%ba%a7%e4%bf%9d%e5%81%a5%ef%bc%9f%e5%89%8d%e7%9e%bb%e6%80%a7/Medxy AIzh2026-05-26T13:10:18-07:00长期甲状腺癌随访能否安全转至初级保健？前瞻性数据显示优秀反应后可降级 https://news.medxy.ai/ja/%e7%94%b2%e7%8a%b6%e8%85%ba%e3%81%8c%e3%82%93%e3%81%ae%e9%95%b7%e6%9c%9f%e3%83%95%e3%82%a9%e3%83%ad%e3%83%bc%e3%82%a2%e3%83%83%e3%83%97%e3%81%af%e4%b8%80%e6%ac%a1%e5%8c%bb%e7%99%82%e3%81%ab%e5%ae%89/Medxy AIja2026-05-26T13:07:42-07:00甲状腺がんの長期フォローアップは一次医療に安全に移行可能か？優れた反応後のデータが減量を支持 https://news.medxy.ai/vi/co-the-chuyen-theo-doi-dai-han-ung-thu-tuyen-giap-sang-cham-soc-ban-dau-khong-du-lieu-trien-vong-ho-tro-giam-cuong-do-sau-khi-dap-ung-xuat-sac/Medxy AIvi2026-05-26T13:03:30-07:00Có thể chuyển theo dõi dài hạn ung thư tuyến giáp sang chăm sóc ban đầu không? Dữ liệu triển vọng hỗ trợ giảm cường độ sau khi đáp ứng xuất sắc https://news.medxy.ai/can-long-term-thyroid-cancer-follow-up-safely-move-to-primary-care-prospective-data-support-de-escalation-after-excellent-response/Medxy AIen2026-05-26T12:57:54-07:00Can Long-Term Thyroid Cancer Follow-Up Safely Move to Primary Care? Prospective Data Support De-Escalation After Excellent Response https://news.medxy.ai/duodenal-recombinant-rordep1-was-safe-and-triggered-early-incretin-insulin-responses-in-healthy-men/Medxy AIen2026-05-26T12:48:49-07:00Duodenal Recombinant RORDEP1 Was Safe and Triggered Early Incretin-Insulin Responses in Healthy Men https://news.medxy.ai/ja/acth%e4%be%9d%e5%ad%98%e6%80%a7%e3%82%af%e3%83%83%e3%82%b7%e3%83%b3%e3%82%b0%e7%97%87%e5%80%99%e7%be%a4%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e3%83%aa%e3%83%90%e3%83%bc%e3%83%ad%e3%82%ad%e3%82%b5/Medxy AIja2026-05-26T12:44:23-07:00ACTH依存性クッシング症候群におけるリバーロキサバンの血栓予防の安全性と有効性 https://news.medxy.ai/vi/an-toan-va-hieu-qua-cua-rivaroxaban-trong-phong-ngua-huyet-khoi-tinh-mach-o-hoi-chung-cushing-phu-thuoc-acth/Medxy AIvi2026-05-26T12:43:10-07:00An toàn và hiệu quả của Rivaroxaban trong phòng ngừa huyết khối tĩnh mạch ở hội chứng Cushing phụ thuộc ACTH https://news.medxy.ai/safety-and-effectiveness-of-rivaroxaban-thromboprophylaxis-in-acth-dependent-cushing-syndrome/Medxy AIen2026-05-26T12:41:27-07:00Safety and Effectiveness of Rivaroxaban Thromboprophylaxis in ACTH-Dependent Cushing Syndrome https://news.medxy.ai/ja/%e3%82%bb%e3%83%9e%e3%82%b0%e3%83%ab%e3%83%81%e3%83%89%e3%81%af%e3%80%81%e7%ac%ac2%e4%b8%96%e4%bb%a3%e6%8a%97%e7%b2%be%e7%a5%9e%e7%97%85%e8%96%ac%e3%82%92%e6%9c%8d%e7%94%a8%e3%81%97%e3%81%a6%e3%81%84/Medxy AIja2026-05-26T11:17:23-07:00セマグルチドは、第2世代抗精神病薬を服用している統合失調症、前糖尿病、肥満患者のインスリン感受性を改善する：HISTORI試験の結果 https://news.medxy.ai/vi/semaglutide-cai-thien-do-nhay-cam-voi-insulin-o-benh-nhan-mac-benh-tam-phan-liet-tien-dai-thao-duong-va-beo-phi-dang-dieu-tri-bang-thuoc-chong-loan-than-the-he-thu-hai-ket-qua-tu-thu-nghiem-histori/Medxy AIvi2026-05-26T11:15:49-07:00Semaglutide cải thiện độ nhạy cảm với insulin ở bệnh nhân mắc bệnh tâm phân liệt, tiền đái tháo đường và béo phì đang điều trị bằng thuốc chống loạn thần thế hệ thứ hai: Kết quả từ thử nghiệm HISTORI https://news.medxy.ai/semaglutide-improves-insulin-sensitivity-in-patients-with-schizophrenia-prediabetes-and-obesity-treated-with-second-generation-antipsychotics-findings-from-the-histori-trial/Medxy AIen2026-05-26T11:14:13-07:00Semaglutide Improves Insulin Sensitivity in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial https://news.medxy.ai/ja/6%e9%80%b1%e9%96%93%e3%81%ae%e3%83%8d%e3%82%a4%e3%83%86%e3%82%a3%e3%83%96gip%e6%8a%95%e4%b8%8e%e3%81%af%e3%80%81%e5%8d%98%e7%8b%ac%e3%81%a7%e3%82%82%e3%82%bb%e3%83%9e%e3%82%b0%e3%83%ab%e3%83%81/Medxy AIja2026-05-26T10:19:33-07:006週間のネイティブGIP投与は、単独でもセマグルチドと併用しても、2型糖尿病の血糖制御を改善しなかった https://news.medxy.ai/vi/viec-tiem-gip-tu-nhien-trong-sau-tuan-khong-cai-thien-kiem-soat-duong-huyet-o-benh-nhan-tieu-duong-tuyp-2-du-dung-don-le-hay-ket-hop-voi-semaglutide/Medxy AIvi2026-05-26T10:18:04-07:00Việc tiêm GIP tự nhiên trong sáu tuần không cải thiện kiểm soát đường huyết ở bệnh nhân tiểu đường tuýp 2, dù dùng đơn lẻ hay kết hợp với semaglutide https://news.medxy.ai/six-week-native-gip-infusion-does-not-improve-glycaemic-control-in-type-2-diabetes-alone-or-with-semaglutide/Medxy AIen2026-05-26T10:16:10-07:00Six-Week Native GIP Infusion Does Not Improve Glycaemic Control in Type 2 Diabetes, Alone or With Semaglutide https://news.medxy.ai/circulating-microrna-scores-may-distinguish-cellular-and-antibody-mediated-heart-transplant-rejection-with-high-accuracy/Medxy AIen2026-05-26T00:27:17-07:00Circulating MicroRNA Scores May Distinguish Cellular and Antibody-Mediated Heart Transplant Rejection With High Accuracy https://news.medxy.ai/ja/%e7%b5%8c%e5%8f%a3%e3%82%bb%e3%83%9e%e3%82%b0%e3%83%ab%e3%83%81%e3%83%89%e3%81%a8%e9%ab%98%e3%83%aa%e3%82%b9%e3%82%af2%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e5%bf%83/Medxy AIja2026-05-26T00:26:22-07:00経口セマグルチドと高リスク2型糖尿病における心血管リスク因子の変化 https://news.medxy.ai/vi/semaglutide-duong-uong-va-su-thay-doi-cac-yeu-to-nguy-co-tim-mach-o-benh-nhan-tieu-duong-type-2-co-nguy-co-cao/Medxy AIvi2026-05-26T00:24:49-07:00Semaglutide đường uống và sự thay đổi các yếu tố nguy cơ tim mạch ở bệnh nhân tiểu đường type 2 có nguy cơ cao https://news.medxy.ai/oral-semaglutide-and-cardiovascular-risk-factor-changes-in-high-risk-type-2-diabetes/Medxy AIen2026-05-26T00:23:17-07:00Oral Semaglutide and Cardiovascular Risk Factor Changes in High-Risk Type 2 Diabetes https://news.medxy.ai/ja/%e6%85%a2%e6%80%a7%e5%86%a0%e7%8a%b6%e5%8b%95%e8%84%88%e7%96%be%e6%82%a3%e3%81%ae%e5%a5%b3%e6%80%a7%ef%bc%9apci%e3%81%a8cabg%e5%be%8c%e3%81%ae%e9%95%b7%e6%9c%9f%e4%ba%88%e5%be%8c/Medxy AIja2026-05-26T00:16:26-07:00慢性冠状動脈疾患の女性：PCIとCABG後の長期予後 https://news.medxy.ai/vi/phu-nu-mac-benh-dong-mach-vanh-man-tinh-ket-qua-dai-han-sau-pci-so-voi-cabg/Medxy AIvi2026-05-26T00:15:01-07:00Phụ nữ mắc bệnh động mạch vành mãn tính: Kết quả dài hạn sau PCI so với CABG https://news.medxy.ai/women-with-chronic-coronary-artery-disease-long-term-outcomes-after-pci-vs-cabg/Medxy AIen2026-05-26T00:12:57-07:00Women with Chronic Coronary Artery Disease: Long-Term Outcomes After PCI vs CABG https://news.medxy.ai/ja/%e6%8b%a1%e5%bc%b5%e5%9e%8b%e5%bf%83%e7%ad%8b%e7%97%87%e3%81%a8%e5%bf%83%e5%be%8b%e5%a4%b1%e5%b8%b8%e6%80%a7%e5%bf%83%e7%ad%8b%e7%97%87%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%80%a7%e5%88%a5%e3%83%bb/Medxy AIja2026-05-26T00:09:19-07:00拡張型心筋症と心律失常性心筋症における性別・年齢特異的遺伝的リスク: SHaReレジストリからの洞察 https://news.medxy.ai/vi/nguy-co-di-truyen-theo-gioi-va-tuoi-trong-benh-co-tim-phi-dai-va-benh-co-tim-loan-nhip-nhung-hieu-biet-tu-dang-ky-share/Medxy AIvi2026-05-26T00:07:25-07:00Nguy cơ di truyền theo giới và tuổi trong bệnh cơ tim phì đại và bệnh cơ tim loạn nhịp: Những hiểu biết từ Đăng ký SHaRe https://news.medxy.ai/sex-and-age-specific-genetic-risk-across-dilated-and-arrhythmogenic-cardiomyopathy-insights-from-the-share-registry/Medxy AIen2026-05-26T00:03:59-07:00Sex- and Age-Specific Genetic Risk Across Dilated and Arrhythmogenic Cardiomyopathy: Insights From the SHaRe Registry https://news.medxy.ai/ja/%e9%ab%98%e8%84%82%e8%9b%8b%e7%99%bda%e5%9c%a8%e6%97%a0%e6%97%a2%e5%be%80%e5%bf%83%e8%82%8c%e6%a2%97%e6%ad%bb%e6%88%96%e4%b8%ad%e9%a3%8e%e7%9a%84%e6%83%85%e5%86%b5%e4%b8%8b%e6%a0%87%e8%ae%b0/Medxy AIja2026-05-25T23:50:39-07:00高脂蛋白(a)在无既往心肌梗死或中风的情况下标记更大的冠状动脉风险，而Evolocumab提供类似的相对益处和更大的绝对获益 https://news.medxy.ai/higher-lipoproteina-marks-greater-coronary-risk-without-prior-mi-or-stroke-while-evolocumab-delivers-similar-relative-benefit-and-larger-absolute-gains/Medxy AIen2026-05-25T23:46:27-07:00Higher Lipoprotein(a) Marks Greater Coronary Risk Without Prior MI or Stroke, While Evolocumab Delivers Similar Relative Benefit and Larger Absolute Gains https://news.medxy.ai/ja/%e8%85%b9%e8%85%94%e5%86%85%e3%81%8a%e3%82%88%e3%81%b3%e9%9d%99%e8%84%88%e5%86%85%e3%83%91%e3%82%af%e3%83%aa%e3%82%bf%e3%82%ad%e3%82%bb%e3%83%ab%e3%81%a8s-1%e3%81%ae%e4%bd%b5%e7%94%a8%e3%81%8c/Medxy AIja2026-05-25T23:42:52-07:00腹腔内および静脈内パクリタキセルとS-1の併用が胃癌腹膜転移患者の生存を改善：フェーズ3試験 https://news.medxy.ai/vi/paclitaxel-tiem-vao-o-bung-va-tinh-mach-ket-hop-voi-s-1-cai-thien-su-song-con-trong-ung-thu-da-day-di-can-mang-bung-thu-nghiem-giai-doan-3/Medxy AIvi2026-05-25T23:41:28-07:00Paclitaxel tiêm vào ổ bụng và tĩnh mạch kết hợp với S-1 cải thiện sự sống còn trong ung thư dạ dày di căn màng bụng: Thử nghiệm giai đoạn 3 https://news.medxy.ai/intraperitoneal-and-intravenous-paclitaxel-plus-s-1-improves-survival-in-gastric-cancer-with-peritoneal-metastasis-phase-3-trial/Medxy AIen2026-05-25T23:38:15-07:00Intraperitoneal and Intravenous Paclitaxel Plus S-1 Improves Survival in Gastric Cancer With Peritoneal Metastasis: Phase 3 Trial https://news.medxy.ai/zh/%e6%8a%97ebv-bnlf2b%e6%8a%97%e4%bd%93%e5%9c%a8%e7%96%91%e4%bc%bc%e9%bc%bb%e5%92%bd%e7%99%8c%e9%97%a8%e8%af%8a%e8%af%8a%e6%96%ad%e4%b8%ad%e6%98%be%e7%a4%ba%e5%87%ba%e9%ab%98%e5%87%86%e7%a1%ae%e6%80%a7/Medxy AIzh2026-05-25T19:50:06-07:00抗EBV BNLF2b抗体在疑似鼻咽癌门诊诊断中显示出高准确性 https://news.medxy.ai/ja/eb%e3%82%a6%e3%82%a4%e3%83%ab%e3%82%b9-bnlf2b-%e6%8a%97%e4%bd%93%e3%80%81%e7%96%91%e3%82%8f%e3%81%97%e3%81%84%e9%bc%bb%e5%92%bd%e9%a0%ad%e3%81%8c%e3%82%93%e3%81%ae%e5%a4%96%e6%9d%a5%e8%a8%ba%e6%96%ad/Medxy AIja2026-05-25T19:48:03-07:00EBウイルス BNLF2b 抗体、疑わしい鼻咽頭がんの外来診断で高精度を示す https://news.medxy.ai/vi/khang-the-chong-ebv-bnlf2b-co-do-chinh-xac-cao-trong-chan-doan-ngoai-tru-ung-thu-vom-hong-nghi-ngo/Medxy AIvi2026-05-25T19:44:44-07:00Kháng thể chống EBV BNLF2b có độ chính xác cao trong chẩn đoán ngoại trú ung thư vòm họng nghi ngờ https://news.medxy.ai/anti-ebv-bnlf2b-antibody-shows-high-accuracy-for-outpatient-diagnosis-of-suspected-nasopharyngeal-carcinoma/Medxy AIen2026-05-25T19:40:27-07:00Anti-EBV BNLF2b Antibody Shows High Accuracy for Outpatient Diagnosis of Suspected Nasopharyngeal Carcinoma https://news.medxy.ai/ja/%e7%96%91%e3%82%8f%e3%81%97%e3%81%84%e9%bc%bb%e5%92%bd%e9%a0%ad%e7%99%8c%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8beb%e3%82%a6%e3%82%a4%e3%83%ab%e3%82%b9bnlf2b%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e6%8a%97/Medxy AIja2026-05-25T19:25:45-07:00疑わしい鼻咽頭癌におけるEBウイルスBNLF2bに対する抗体の診断性能 https://news.medxy.ai/vi/hieu-suat-chan-doan-cua-khang-the-chong-vi-rut-epstein-barr-bnlf2b-trong-u-nhay-mui-hong-nghi-ngo/Medxy AIvi2026-05-25T19:24:06-07:00Hiệu suất chẩn đoán của kháng thể chống vi-rút Epstein-Barr BNLF2b trong u nhầy mũi họng nghi ngờ https://news.medxy.ai/diagnostic-performance-of-anti-epstein-barr-virus-bnlf2b-in-suspected-nasopharyngeal-carcinoma/Medxy AIen2026-05-25T19:21:41-07:00Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma